Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

636 ARTÍCULOS , VIENDO DEL 421 AL 435

HPCA confirmed as a genetic cause of DYT2-like dystonia phenotype

Atasu B, Hanagasi H, Bilgic B, Pak M, Erginel-Unaltuna N, Hauser AK, Guven G, Simón-Sánchez J, Heutink P, Gasser T, Lohmann E.

Mov Disord. 2018 Aug;33(8):1354-1358. doi: 10.1002/mds.27442. Epub 2018 Aug 25.

Sustained quality-of-life improvements over 10 years after deep brain stimulation for dystonia

Hogg E, During E, E Tan E, Athreya K, Eskenazi J, Wertheimer J, Mamelak AN, Alterman RL, Tagliati M.

Mov Disord. 2018 Jul;33(7):1160-1167. doi: 10.1002/mds.27426.

Dystonia: Are animal models relevant in therapeutics?

Meringolo M, Tassone A, Imbriani P, Ponterio G, Pisani A.

Rev Neurol (Paris). 2018 Nov;174(9):608-614. doi: 10.1016/j.neurol.2018.07.003. Epub 2018 Aug 25.

Monoamine neurotransmitters and movement disorders in children and adults

Doummar D, Moussa F, Nougues MC, Ravelli C, Louha M, Whalen S, Burglen L, Rodriguez D, Billette de Villemeur T.

Rev Neurol (Paris). 2018 Nov;174(9):581-588. doi: 10.1016/j.neurol.2018.07.002. Epub 2018 Aug 27.

Deep brain stimulation for childhood dystonia: current evidence and emerging practice

Elkaim LM, De Vloo P, Kalia SK, Lozano AM, Ibrahim GM.

Expert Rev Neurother. 2018 Oct;18(10):773-784. doi: 10.1080/14737175.2018.1523721. Epub 2018 Sep 24.

Neurostimulation in tardive dystonia/dyskinesia: A delayed start, sham stimulation-controlled randomized trial

Gruber D, Südmeyer M, Deuschl G, Falk D, Krauss JK, Mueller J, Müller JU, Poewe W, Schneider GH, Schrader C, Vesper J, Volkmann J, Winter C, Kupsch A, Schnitzler A; DBS study group for dystonia.

Brain Stimul. 2018 Nov-Dec;11(6):1368-1377. doi: 10.1016/j.brs.2018.08.006. Epub 2018 Sep 11.

Functional movement disorders of the face: A historical review and case series

Stone J, Hoeritzauer I, Tesolin L, Carson A.

J Neurol Sci. 2018 Dec 15;395:35-40. doi: 10.1016/j.jns.2018.09.031. Epub 2018 Sep 26.

Cellular and Molecular Mechanisms of Recessive Hereditary Methaemoglobinaemia Type II

Siendones E, Ballesteros M, Navas P.

J Clin Med. 2018 Oct 10;7(10):341. doi: 10.3390/jcm7100341.

Predictors of alcohol responsiveness in dystonia

Junker J, Brandt V, Berman BD, Vidailhet M, Roze E, Weissbach A, Comella C, Malaty IA, Jankovic J, LeDoux MS, Berardelli A, Barbano R, Reich SG, Perlmutter JS, Jinnah HA, Brüggemann N.

Neurology. 2018 Nov 20;91(21):e2020-e2026. doi: 10.1212/WNL.0000000000006551. Epub 2018 Oct 19.

Compound heterozygous mutations in the TH gene in a Chinese family with autosomal-recessive dopa-responsive dystonia: A case report

Feng B, Sun G, Kong Q, Li Q.

Medicine (Baltimore). 2018 Nov;97(44):e12870. doi: 10.1097/MD.0000000000012870.

A probable case of movement disorder (Tardive dyskinesia) due to duloxetine treatment

Yılmaz R, Üstün D, Tuncer Uzun S, Reisli R, Türk Ş.

Agri. 2018 Oct;30(4):199-201. doi: 10.5505/agri.2018.60134.

Staged bilateral pallidotomy for dystonic camptocormia: case report

Horisawa S, Oka M, Kohara K, Kawamata T, Taira T.

J Neurosurg. 2018 Oct 19;131(3):839-842. doi: 10.3171/2018.5.JNS1840. Print 2019 Sep 1.

Why orthotic devices could be of help in the management of Movement Disorders in the young

Garavaglia L, Pagliano E, Baranello G, Pittaccio S.

J Neuroeng Rehabil. 2018 Dec 14;15(1):118. doi: 10.1186/s12984-018-0466-8.

Paroxysmal Dyskinesias in a PRRT2 Mutation Carrier

Marano M, Motolese F, Consoli F, De Luca A, Di Lazzaro V.

Tremor Other Hyperkinet Mov (N Y). 2018 Dec 3;8:616. doi: 10.7916/D8S488X0. eCollection 2018.

Potential indications for deep brain stimulation in neurological disorders: an evolving field

Budman E, Deeb W, Martinez-Ramirez D, Pilitsis JG, Peng-Chen Z, Okun MS, Ramirez-Zamora A.

Eur J Neurol. 2018 Mar;25(3):434-e30. doi: 10.1111/ene.13548. Epub 2018 Feb 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias